Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ritter

Showing results (741-750 of 756) with videos related to

Pageof 76
Sort By:
Oncotarget|June 15, 2018
Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patientsSascha Marx, Maximilian Splittstöhser, Frederik Kinnen, et al.
Surgical Infections|May 6, 2022
Surgical Infection Society: Chest Wall Injury Society Recommendations for Antibiotic Use during Surgical Stabilization of Traumatic Rib or Sternal Fractures to Reduce Risk of Implant InfectionJoseph D Forrester, Marko Bukur, Justin E Dvorak, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2000
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406J M Michalski, J A Purdy, K Winter, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2023
Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 TrialBrett A Morris, Emma E Holmes, Nicholas J Anger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 2010
Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracilPraveen K Nambaru, Tobias Hübner, Kathleen Köck, et al.
Practical Radiation Oncology|February 9, 2025
Neoadjuvant SBRT plus Elective Nodal Irradiation with Concurrent Capecitabine for Patients with Resectable Pancreatic Cancer: Survival Analysis of a Prospective Phase 1 TrialMustafa M Basree, Jacob S Witt, Nataliya V Uboha, et al.
Annals of Neurology|February 21, 2013
Thalamic involvement in patients with neurologic impairment due to Shiga toxin 2Sven G Meuth, Kerstin Göbel, Tatyana Kanyshkova, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2020
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic CancerJacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|September 20, 2013
Tragedy into drama: an american history of tourniquet use in the current warJohn F Kragh, Thomas J Walters, Ted Westmoreland, et al.
JAMA|November 29, 2016
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in WomenOle-Erik Iversen, Maria Jose Miranda, Angels Ulied, et al.
Pageof 76

Showing results (741-750 of 756) with videos related to

Sort By:
Pageof 76
Oncotarget|June 15, 2018
Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patientsSascha Marx, Maximilian Splittstöhser, Frederik Kinnen, et al.
Surgical Infections|May 6, 2022
Surgical Infection Society: Chest Wall Injury Society Recommendations for Antibiotic Use during Surgical Stabilization of Traumatic Rib or Sternal Fractures to Reduce Risk of Implant InfectionJoseph D Forrester, Marko Bukur, Justin E Dvorak, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2000
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406J M Michalski, J A Purdy, K Winter, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2023
Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 TrialBrett A Morris, Emma E Holmes, Nicholas J Anger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 2010
Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracilPraveen K Nambaru, Tobias Hübner, Kathleen Köck, et al.
Practical Radiation Oncology|February 9, 2025
Neoadjuvant SBRT plus Elective Nodal Irradiation with Concurrent Capecitabine for Patients with Resectable Pancreatic Cancer: Survival Analysis of a Prospective Phase 1 TrialMustafa M Basree, Jacob S Witt, Nataliya V Uboha, et al.
Annals of Neurology|February 21, 2013
Thalamic involvement in patients with neurologic impairment due to Shiga toxin 2Sven G Meuth, Kerstin Göbel, Tatyana Kanyshkova, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2020
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic CancerJacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|September 20, 2013
Tragedy into drama: an american history of tourniquet use in the current warJohn F Kragh, Thomas J Walters, Ted Westmoreland, et al.
JAMA|November 29, 2016
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in WomenOle-Erik Iversen, Maria Jose Miranda, Angels Ulied, et al.
Pageof 76